Does MOSUNETUZUMAB-AXGB Cause Disease progression? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Disease progression have been filed in association with MOSUNETUZUMAB-AXGB. This represents 12.6% of all adverse event reports for MOSUNETUZUMAB-AXGB.
25
Reports of Disease progression with MOSUNETUZUMAB-AXGB
12.6%
of all MOSUNETUZUMAB-AXGB reports
2
Deaths
9
Hospitalizations
How Dangerous Is Disease progression From MOSUNETUZUMAB-AXGB?
Of the 25 reports, 2 (8.0%) resulted in death, 9 (36.0%) required hospitalization, and 1 (4.0%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOSUNETUZUMAB-AXGB. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does MOSUNETUZUMAB-AXGB Cause?
Cytokine release syndrome (52)
Pyrexia (27)
Off label use (20)
Rash (18)
No adverse event (16)
Neutropenia (13)
Thrombocytopenia (9)
Chills (8)
Fatigue (8)
Death (7)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which MOSUNETUZUMAB-AXGB Alternatives Have Lower Disease progression Risk?
MOSUNETUZUMAB-AXGB vs MOXIFLOXACIN
MOSUNETUZUMAB-AXGB vs MOXIFLOXACIN\MOXIFLOXACIN
MOSUNETUZUMAB-AXGB vs MOXONIDINE
MOSUNETUZUMAB-AXGB vs MS CONTIN
MOSUNETUZUMAB-AXGB vs MULTAQ